Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Zebra 365 who wrote (8702)	5/29/1998 8:14:00 PM
From: VLAD	Respond to of 23519

Zebra, Although I don't know the exact truth, all the comments I have read by MDs about Vasomax suggest that the drug is relatively worthless. If this is the case, why should it effect the price of Vivus stock? Even if the stuff was given away free, if it doesn't work who really cares. BTW, if it does work, I understand that it will only be helpful as an enhancer and maybe in some mild cases. Again as we have discussed before, even if there are 20 different oral ED drugs they will all be competing in the systemic arena. If a pill ever comes out that is inexpensive and works well with no side effects then I would no longer believe in MUSE. However, I don't think such a drug will ever be developed -- it is just a dream in the minds of the hypesters and touters. I wonder how many media people loaded the boat on ICOS before all the horn blowing. I bet they made a killing.